M

Medicinova

D
MNOV
USD
-0.04
(-2.4845%)
Market Closed
245.000
Volume
-0.23
EPS
-
Div Yield
-9.812500
P/E
77,002,606.22
Market Cap
Today
0.6410%
1 Week
-6.548%
1 Month
-21.106%
6 Months
17.164%
12 Months
-16.931%
Year To Date
4.667%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ARWR
0.055
(0.2579%)
USD
T
TRVN
-2.02
(-44.9889%)
USD
N
NVAX
0.23
(2.5713%)
USD
V
VKTX
2.97
(4.5075%)
USD
C
CRVS
-0.74
(-7.7568%)
USD
B
BNTC
0.545
(5.2228%)
USD

Title:
Medicinova

Sector:
Healthcare
Industry:
Biotechnology
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Do you need help or have a question?
Contact Us